BioWorld MedTech

May 16, 2012

EuroPCR 2012: Valve-in-valve will open vast opportunity for TAVI

PARIS Champagne was served all around, even for journalists, to celebrate the tenth anniversary of the first transcatheter valve implantation (TAVI) in May, 2002 in Rouen, France. Read More

MedTech Investing Conference: Leahey: Stakes for med-tech sector have never been higher

Svelte Medical Systems completes enrollment in DIRECT DES study

Washington roundup: DoJ said to be offering 'some leeway' in ICD investigation

Deals roundup: CryoLife set to pay up to $21.5M to buy Hemosphere

Agreements/contracts: Novation gives EarlySense's monitoring new innovation tag

Grants roundup: DMRDP recommends $2M for Accelr8, Denver Health project

EuroPCR 2012 notebook: St. Jude gets CE mark for EnligHTN renal system

Med-Tech Notes: ChartLogic expands orthopedic offering

HIT roundup: NextGen inks new agreement with NSHC for HIT solutions

Report from Europe: Abbott's Xience Prime and Xience V receive CE mark

Court report: RyMed's victory clears path for InVision-Plus

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Aug. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 21, 2025.

FDA approved icons and medical professional

Ionis gets approval for preventing attacks in rare and genetic HAE

BioWorld

In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and...

Elderly woman holding illustration of brain with missing puzzle piece

Marvel Biotechnology’s MB-204 as therapeutic agent for Alzheimer’s disease

BioWorld Science

Phosphorylation of the protein Tau is a key post-translational feature in tauopathies like Alzheimer’s disease (AD), which leads to microtubule dysfunction and...

Wooden blocks spelling TARIFFS with a U.S. flag on top, placed on a map of Europe

EU, US lock in 15% max Rx tariff, no relief for medtech

BioWorld

No matter what level of tariff the Trump administration ends up imposing on biopharmaceuticals across the world, drugs and their precursors originating in the EU...